CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS
/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that it will release its third quarter 2022...
Stay updated with breaking news from Systemic Sclerosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that it will release its third quarter 2022...
The Global Allergy Immunotherapy Market Size was valued at USD 2.0 billion in 2021 and the worldwide allergy immunotherapy market share is expected to...
The Global CRISPR Technology Market Size was valued at USD 2,251.21 Million in 2021 and the worldwide CRISPR technology market is expected to reach USD...
Gender-affirming hormone therapy does not need to be a strict contraindication in transgender patients with rheumatic disease, an author of a new case series and systematic review said.
The rise in blood disorders and other diseases, the quick development of haematology technology, and the appearance of high throughput haematology...